Our study systematically analyzed FCHSD1 in a pan-carcinogenic manner, evaluated the potential association of FCHSD1 expression with pathological stage, immunophenotype, immune cell infiltration, genetics, prognosis, drug sensitivity, etc. in various cancer types. This evidence concerns the gene FCHSD1 and cancer.